{"abstract": "Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients\u2019 requests for lifesaving medicines before they are approved.", "web_url": "https://www.nytimes.com/2015/05/07/business/company-creates-bioethics-panel-on-trial-drugs.html", "snippet": "Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients\u2019 requests for lifesaving medicines before they are approved.", "lead_paragraph": "Johnson & Johnson has appointed a nationally known bioethicist to create a panel that will make decisions about patients\u2019 requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they are approved.", "print_section": "A", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/05/07/business/Ethics/Ethics-articleLarge.jpg", "height": 936, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/05/07/business/Ethics/Ethics-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 936}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/05/07/business/Ethics/Ethics-jumbo.jpg", "height": 984, "width": 631, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/05/07/business/Ethics/Ethics-superJumbo.jpg", "height": 984, "width": 631, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/05/07/business/Ethics/Ethics-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/05/07/business/Ethics/Ethics-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/05/07/business/Ethics/Ethics-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Company Creates Bioethics Panel on Trial Drugs", "kicker": null, "content_kicker": null, "print_headline": "Company Creates Panel for Access to Trial Drugs", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Thomas, Katie", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 2, "major": "N"}, {"name": "persons", "value": "Caplan, Arthur L", "rank": 3, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 4, "major": "N"}, {"name": "organizations", "value": "New York University Langone Medical Center", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Chimerix Inc", "rank": 7, "major": "N"}, {"name": "subject", "value": "Ethics and Official Misconduct", "rank": 8, "major": "N"}], "pub_date": "2015-05-07T04:01:15+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/33bf8157-acaf-5847-8be6-234e9850e1c6", "word_count": 1614, "uri": "nyt://article/33bf8157-acaf-5847-8be6-234e9850e1c6"}